Antiproliferative Activity of a New Quinazolin-4(3<i>H</i>)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common lung cancer subtype. Although chemotherapy and targeted therapy are used for the treatment of patients with NSCLC, the survival rate remains very low. Recent findings suggested that aurora kinase A (AKA), a cell cycle regulator, is a potential ta...
Main Authors: | Ji Yun Lee, Huarong Yang, Donghwa Kim, Kay Zin Kyaw, Ruoci Hu, Yanhua Fan, Sang Kook Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/6/698 |
Similar Items
-
2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation
by: Mohamed H. Elsherbeny, et al.
Published: (2022-06-01) -
The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study
by: Ali S. Alqahtani, et al.
Published: (2022-02-01) -
Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors
by: M.S. Raghu, et al.
Published: (2023-09-01) -
Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)
by: Alexandru Șandor, et al.
Published: (2023-04-01) -
The aurorae/
by: 223790 Harang, Leiv
Published: (1951)